Please assess the completion status of the following clinical trial:

Trial Title: The Role of Incretins in Bone Remodeling in Humans

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* healthy women and men~Exclusion Criteria:~* known osteoporosis~* osteoporotic fracture~* tobacco~* alcohol : \> 2 glasses/day~* type 1 and type 2 diabetes~* BMI \< 19kg/m² or \> 30kg/m²~* heart failure, kidney failure~* cancer~* bariatric surgery~* graft~* cirrhosis~* use in the past year : bisphosphonate, denosumab, raloxifene, teriparatide, oral or IV glucocorticoid during 3 months or more

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).